Cargando…
Analysis of Peripherally Inserted Central Catheter Line in Cancer Patients: A Single-Center Experience
Background Peripherally inserted central venous catheters are now widely used in cancer patients who require long-term treatment, for delivering multiple infusates. We aimed to evaluate the overall use of peripherally inserted central catheter (PICC) line in cancer patients, with the objective to s...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Private Ltd
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205555/ https://www.ncbi.nlm.nih.gov/pubmed/34141688 http://dx.doi.org/10.1055/s-0040-1721175 |
_version_ | 1783708526312423424 |
---|---|
author | Sapkota, Sulav Sannur, Raju Naik, Radheshyam |
author_facet | Sapkota, Sulav Sannur, Raju Naik, Radheshyam |
author_sort | Sapkota, Sulav |
collection | PubMed |
description | Background Peripherally inserted central venous catheters are now widely used in cancer patients who require long-term treatment, for delivering multiple infusates. We aimed to evaluate the overall use of peripherally inserted central catheter (PICC) line in cancer patients, with the objective to study the demographic profile, complications, and safety related to PICC line in cancer patients. Methods All the patients undergoing treatment for hematological and solid malignancies with PICC line inserted at the Healthcare Global Hospital during the study were evaluated prospectively. The complications related to PICC and its safety were analyzed. Results Five hundred PICCs were inserted over a period of 2 years to 8 months for a total of 62,440 catheter days (mean of 24 days, i.e., 4.2 months, range: 1–434 days). The most common indication for PICC was for delivering chemotherapy (100%). Of these, 51 (10.2%) PICCs had complications at the rate of 0.82/1000 PICC days, and hence, 41 PICCs were removed. Hematological malignancies had more complications as compared with those with solid malignancies. Conclusions PICCs are comparatively safe method for the central venous access in cancer patients. |
format | Online Article Text |
id | pubmed-8205555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Thieme Medical and Scientific Publishers Private Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-82055552021-06-16 Analysis of Peripherally Inserted Central Catheter Line in Cancer Patients: A Single-Center Experience Sapkota, Sulav Sannur, Raju Naik, Radheshyam South Asian J Cancer Background Peripherally inserted central venous catheters are now widely used in cancer patients who require long-term treatment, for delivering multiple infusates. We aimed to evaluate the overall use of peripherally inserted central catheter (PICC) line in cancer patients, with the objective to study the demographic profile, complications, and safety related to PICC line in cancer patients. Methods All the patients undergoing treatment for hematological and solid malignancies with PICC line inserted at the Healthcare Global Hospital during the study were evaluated prospectively. The complications related to PICC and its safety were analyzed. Results Five hundred PICCs were inserted over a period of 2 years to 8 months for a total of 62,440 catheter days (mean of 24 days, i.e., 4.2 months, range: 1–434 days). The most common indication for PICC was for delivering chemotherapy (100%). Of these, 51 (10.2%) PICCs had complications at the rate of 0.82/1000 PICC days, and hence, 41 PICCs were removed. Hematological malignancies had more complications as compared with those with solid malignancies. Conclusions PICCs are comparatively safe method for the central venous access in cancer patients. Thieme Medical and Scientific Publishers Private Ltd 2020-10 2021-06-15 /pmc/articles/PMC8205555/ /pubmed/34141688 http://dx.doi.org/10.1055/s-0040-1721175 Text en MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Sapkota, Sulav Sannur, Raju Naik, Radheshyam Analysis of Peripherally Inserted Central Catheter Line in Cancer Patients: A Single-Center Experience |
title | Analysis of Peripherally Inserted Central Catheter Line in Cancer Patients: A Single-Center Experience |
title_full | Analysis of Peripherally Inserted Central Catheter Line in Cancer Patients: A Single-Center Experience |
title_fullStr | Analysis of Peripherally Inserted Central Catheter Line in Cancer Patients: A Single-Center Experience |
title_full_unstemmed | Analysis of Peripherally Inserted Central Catheter Line in Cancer Patients: A Single-Center Experience |
title_short | Analysis of Peripherally Inserted Central Catheter Line in Cancer Patients: A Single-Center Experience |
title_sort | analysis of peripherally inserted central catheter line in cancer patients: a single-center experience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205555/ https://www.ncbi.nlm.nih.gov/pubmed/34141688 http://dx.doi.org/10.1055/s-0040-1721175 |
work_keys_str_mv | AT sapkotasulav analysisofperipherallyinsertedcentralcatheterlineincancerpatientsasinglecenterexperience AT sannurraju analysisofperipherallyinsertedcentralcatheterlineincancerpatientsasinglecenterexperience AT naikradheshyam analysisofperipherallyinsertedcentralcatheterlineincancerpatientsasinglecenterexperience |